According to Stryker Corporation's latest financial reports the company has $3.05 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $3.05 B | 58.35% |
2022-12-31 | $1.92 B | -36.14% |
2021-12-31 | $3.01 B | -0.17% |
2020-12-31 | $3.02 B | -31.66% |
2019-12-31 | $4.42 B | 19.63% |
2018-12-31 | $3.69 B | 32.44% |
2017-12-31 | $2.79 B | -17.46% |
2016-12-31 | $3.38 B | -17.04% |
2015-12-31 | $4.07 B | -18.42% |
2014-12-31 | $5.00 B | 25.63% |
2013-12-31 | $3.98 B | -7.12% |
2012-12-31 | $4.28 B | 25.37% |
2011-12-31 | $3.41 B | -21.96% |
2010-12-31 | $4.38 B | 48.23% |
2009-12-31 | $2.95 B | 34.58% |
2008-12-31 | $2.19 B | -8.93% |
2007-12-31 | $2.41 B | 70.4% |
2006-12-31 | $1.41 B | 33.91% |
2005-12-31 | $1.05 B | 202.38% |
2004-12-31 | $0.34 B | 430.2% |
2003-12-31 | $65.9 M | 74.34% |
2002-12-31 | $37.8 M | -24.55% |
2001-12-31 | $50.1 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Medtronic MDT | $8.32 B | 172.55% | ๐ฎ๐ช Ireland |
Baxter BAX | $3.19 B | 4.62% | ๐บ๐ธ USA |
Boston Scientific BSX | $0.86 B | -71.67% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $1.64 B | -46.13% | ๐บ๐ธ USA |
Waters Corporation WAT | $0.39 B | -87.03% | ๐บ๐ธ USA |
Integra LifeSciences IART | $0.30 B | -89.88% | ๐บ๐ธ USA |
Smith & Nephew
SNN | $0.30 B | -90.11% | ๐ฌ๐ง UK |
Owens & Minor
OMI | $0.24 B | -92.04% | ๐บ๐ธ USA |
Hill-Rom HRC | N/A | N/A | ๐บ๐ธ USA |